Cite
A novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cells.
MLA
Zhen, Ni, et al. “A Novelly Synthesized Phenanthroline Derivative Is a Promising DNA-Damaging Anticancer Agent Inhibiting G1/S Checkpoint Transition and Inducing Cell Apoptosis in Cancer Cells.” Cancer Chemotherapy & Pharmacology, vol. 77, no. 1, Jan. 2016, pp. 169–80. EBSCOhost, https://doi.org/10.1007/s00280-015-2894-5.
APA
Zhen, N., Yang, Q., Wu, Q., Zhu, X., Wang, Y., Sun, F., Mei, W., & Yu, Y. (2016). A novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cells. Cancer Chemotherapy & Pharmacology, 77(1), 169–180. https://doi.org/10.1007/s00280-015-2894-5
Chicago
Zhen, Ni, Qingyuan Yang, Qiong Wu, Xinyi Zhu, Yue Wang, Fenyong Sun, Wenjie Mei, and Yongchun Yu. 2016. “A Novelly Synthesized Phenanthroline Derivative Is a Promising DNA-Damaging Anticancer Agent Inhibiting G1/S Checkpoint Transition and Inducing Cell Apoptosis in Cancer Cells.” Cancer Chemotherapy & Pharmacology 77 (1): 169–80. doi:10.1007/s00280-015-2894-5.